Creating a promising pathway for faster access to new drugs — and a Califf confirmation

  • STAT | by: Peter J. Pitts |
  • 02/14/2022 12:00 AM
Creating a promising pathway for faster access to new drugs — and a Califf confirmation
Illustration credit: bowie15 Getty Images

The FDA’s accelerated approval pathway has a potentially prominent champion — Robert Califf, the scientist President Biden has nominated to lead the FDA.

This pathway opens the door to earlier approval of drugs aimed at serious conditions that fill an unmet medical need based on a surrogate endpoint, which can considerably shorten the time required to submit data to the FDA and expedite the agency’s review process.

At his confirmation hearing in December, Califf said he is “a fan of accelerated approval for the right conditions.”

Six weeks later, Senator Ron Wyden (D-Ore.), who chairs the U.S. Senate’s Committee on Finance, sent Califf a letter asking him to clarify his position on accelerated approval. He asked Califf five important questions:
  • What standard will you use to determine whether a company has failed to comply with confirmatory evidence requirements?
  • How do you expect to hold laggard companies accountable? Which of the existing FDA authorities will you use?
  • How will you measure compliance with clear enforcement standards?
  • If these actions do not lead to success, will you request additional authorities from Congress?
  • How will you use your position to prioritize policy reforms that use existing authority to fix the problems for drugs with accelerated approval when they have yet to provide evidence for confirming their effect?
Sign Up for Our Email Newsletter

RECENT NEWS

Why the FTC is Investigating Pharmacy Benefit Managers

Why the FTC is Investigating Pharmacy Benefit Managers

In money matters, U.S. regulators are investigating claims by PBMs who say they save you money on prescriptions....  Read more

Uh-oh, he’s back: Fauci is once again spouting bad COVID advice

Uh-oh, he’s back: Fauci is once again spouting bad COVID advice

Let’s face it: public-health messaging and open, honest debate haven’t been the Good Doctor’s strong suits. ...  Read more

Peter Pitts speaks to CNN about baby formula shortage
  • CNN
  • 05/13/2022 12:00 AM

Peter Pitts speaks to CNN about baby formula shortage

Former FDA Associate Commissioner Peter Pitts speaks with CNN on the shortage of baby formula on May 13, 2022....  Read more

DRUGWONKS BLOG